SR ONE CAPITAL MANAGEMENT, LLC's Net Worth

Estimate Recalculated Nov 1, 2024 10:19AM EST

Who is SR ONE CAPITAL MANAGEMENT, LLC

SR ONE CAPITAL MANAGEMENT, LLC does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Arcellx, Inc., eFFECTOR Therapeutics, Inc., and Design Therapeutics, Inc..

SEC CIK

SR ONE CAPITAL MANAGEMENT, LLC's CIK is 0001853723

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Arcellx, Inc.

Investor

Updated May 15, 2023

View Quote Details


Form 4	-18.42%	-1.01M	$45.01	-$45.59M	May 15, 2023	4.49M	Sale	—	May 11
Form 4	43.48%	1.67M	$15.00	—	Feb 10, 2022	5.50M	Purchase	—	Feb 08
Form 3	—	—	—	—	Feb 03, 2022	—	—	—	—

Showing 3 results

eFFECTOR Therapeutics, Inc.

Investor

Updated Nov 29, 2023

View Quote Details


Form 4	-8.93%	-609.16K	$0.61	-$369.46K	Nov 29, 2023	6.21M	Sale	—	Nov 27
Form 3	—	—	—	—	Sep 02, 2021	6.82M	—	—	—

Showing 2 results

Zenas BioPharma, Inc.

Investor

Updated Sep 16, 2024

View Quote Details


Form 4	-78.86%	-18.33M	$17.00	—	Sep 16, 2024	4.91M	Buy-Options	—	Sep 16
Form 3	—	—	—	—	Sep 12, 2024	—	—	—	—

Showing 2 results

Design Therapeutics, Inc.

Investor

Updated Dec 20, 2022

View Quote Details


Form 4	16.00%	900.00K	$8.42	$7.57M	Dec 20, 2022	6.53M	Purchase	—	Dec 16 - Dec 20
Form 4	-35.80%	-3.14M	$20.00	—	Apr 01, 2021	5.63M	Buy-Options	—	Mar 30
Form 3/A	—	—	—	—	Mar 30, 2021	—	—	—	—

Showing 3 results